Elixir Corporate Limited Information

Elixir has worked with the C-suite/boards of over 50 public/private corporates, venture funds and NHS Trusts, across the biopharmaceutical ecosystem including in biotech, Medtech, healthtech clinical research services and healthcare distribution. Elixir combines data and experience to deliver strategic partnerships, sell-/buy-side M&A and special situation structures (“roll-ups” and risk sharing partnerships) with responsibility for end-to-end deal management, typically involving strategic landscaping, origination and execution workstreams.